These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8034877)

  • 1. The art and science of mixing and matching.
    Maloney JD; Khoury DS; Zhu W; Rizo-Patron C
    J Am Coll Cardiol; 1994 Aug; 24(2):414-5. PubMed ID: 8034877
    [No Abstract]   [Full Text] [Related]  

  • 2. A Food and Drug Administration request for cooperation.
    Jones JD; Callahan TJ; Alpert S; Barnett M
    J Am Coll Cardiol; 1994 Aug; 24(2):413. PubMed ID: 8034876
    [No Abstract]   [Full Text] [Related]  

  • 3. Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest?
    Zipes DP
    Circulation; 1995 Apr; 91(8):2115-7. PubMed ID: 7697837
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical device preemption after Medtronic, Inc. v. Lohr.
    Neraas MB
    Food Drug Law J; 1996; 51(4):619-29. PubMed ID: 11797731
    [No Abstract]   [Full Text] [Related]  

  • 5. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr.
    Jarcho DG
    Food Drug Law J; 1996; 51(4):613-8. PubMed ID: 11797730
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac arrest and hypertrophic cardiomyopathy. Role of the implantable defibrillator.
    Lefroy DC
    BMJ; 1994 Nov; 309(6964):1277-9. PubMed ID: 7888852
    [No Abstract]   [Full Text] [Related]  

  • 7. Alternative heart therapy: Defibrillator is less invasive, called cost-effective.
    Lee J
    Mod Healthc; 2012 Oct; 42(44):12-3. PubMed ID: 23227668
    [No Abstract]   [Full Text] [Related]  

  • 8. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework?
    Basile EM; Lorell BH
    Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031
    [No Abstract]   [Full Text] [Related]  

  • 9. Advanced heart failure requiring three devices for survival.
    Schmidt B; Siegenthaler MP; Bode C; Beyersdorf F; Zehender M
    Ann Thorac Surg; 2003 Nov; 76(5):1747. PubMed ID: 14602335
    [No Abstract]   [Full Text] [Related]  

  • 10. [Automatic defibrillator or anti-arrhythmia drugs for the therapy of patients who survived heart arrest or with syncopal ventricular arrhythmias? A critical analysis of the models relative to the studies in progress].
    Cappato R; Kuck KH
    G Ital Cardiol; 1994 Dec; 24(12):1613-21. PubMed ID: 7883135
    [No Abstract]   [Full Text] [Related]  

  • 11. Late failure of a single-coil transvenous implantable cardioverter-defibrillator lead associated with conductor separation.
    Richards MW; Warren CE; Anderson MH
    Europace; 2010 Aug; 12(8):1191-2. PubMed ID: 20348555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.
    Tsai VW; Cooper J; Garan H; Natale A; Ptaszek LM; Ellinor PT; Hickey K; Downey R; Zei P; Hsia H; Wang P; Hunt S; Haddad F; Al-Ahmad A
    Circ Heart Fail; 2009 May; 2(3):197-201. PubMed ID: 19808340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F.D.A. had report of short circuit in heart devices; confidentiality at issue; policies of regulator may keep data on problems away from doctors.
    Meier B
    N Y Times Web; 2005 Sep; ():A1, A18. PubMed ID: 16231870
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical-device safety and the FDA.
    Schultz DG
    N Engl J Med; 2008 Jul; 359(1):88-9; author reply 89. PubMed ID: 18596278
    [No Abstract]   [Full Text] [Related]  

  • 15. In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival: results from the AVID Registry. Antiarrhythmics Versus Implantable Defibrillators.
    Epstein AE; Powell J; Yao Q; Ocampo C; Lancaster S; Rosenberg Y; Cannom DS; Herre JM; Greene HL
    J Am Coll Cardiol; 1999 Oct; 34(4):1111-6. PubMed ID: 10520799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring an unstable heart. Implantable cardioverter-defibrillators.
    Mayo Clin Health Lett; 2006 Jun; 24(6):1-3. PubMed ID: 16830395
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of the implantable cardioverter-defibrillator in patients with coronary artery spasm as the apparent cause of spontaneous life-threatening ventricular tachycardia or ventricular fibrillation: crossing the spasm sudden death chasm.
    Mitchell LB
    J Am Coll Cardiol; 2012 Sep; 60(10):914-6. PubMed ID: 22840526
    [No Abstract]   [Full Text] [Related]  

  • 18. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
    Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Stevenson LW; Varosy PD; Welikovitch L
    Circulation; 2014 Jul; 130(1):94-125. PubMed ID: 24815500
    [No Abstract]   [Full Text] [Related]  

  • 19. Implants with flaws: disclosure and delay.
    Meier B
    N Y Times Web; 2005 Jun; ():C1, C3. PubMed ID: 15966120
    [No Abstract]   [Full Text] [Related]  

  • 20. Automated external defibrillation.
    Hess EP; White RD
    Crit Care Clin; 2012 Apr; 28(2):143-53. PubMed ID: 22433479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.